Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

China flag China · Delayed Price · Currency is CNY
23.26
-0.57 (-2.39%)
At close: Apr 29, 2026
-6.17%
Market Cap 9.80B
Revenue (ttm) 1.39B
Net Income (ttm) 131.79M
Shares Out 411.25M
EPS (ttm) 0.32
PE Ratio 74.47
Forward PE n/a
Dividend 0.80 (3.38%)
Ex-Dividend Date Jun 10, 2025
Volume 4,040,772
Average Volume 1,628,584
Open 23.47
Previous Close 23.83
Day's Range 23.02 - 23.47
52-Week Range 23.26 - 29.63
Beta 0.59
RSI 38.80
Earnings Date Apr 21, 2026

About SHA:688739

Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use worldwide. It offers inactivated Japanese encephalitis vaccine (IJEV) and SPEEDA-rabies vaccine. The company’s rabies and influenza vaccines are in the new drug application stage; haemophilus influenzae type b vaccine in phase III; recombinant human papillomavirus 15-valent vaccine is in phase II; and 13-valent pneumococcal polysaccharide conjugate and varicella, as well as the live meningococ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 1,788
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688739
Full Company Profile

Financial Performance

In 2025, SHA:688739's revenue was 1.39 billion, a decrease of -17.06% compared to the previous year's 1.68 billion. Earnings were 131.79 million, a decrease of -61.56%.

Financial Statements

News

There is no news available yet.